Candidiasis of the Skin

• FDA approval · 2022-03-04
  FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Alembic Pharmaceuticals Inc.)

  FDA approved an Original Application for a generic Nystatin and Triamcinolone Acetonide topical product from Alembic Pharmaceuticals Inc.

• FDA approval · 2019-02-15
  FDA Approved: CLOTRIMAZOLE — Original Application (Novitium Pharma LLC)

  FDA approved the original application for clotrimazole topical from Novitium Pharma LLC, a generic topical antifungal.

• FDA approval · 2017-12-26
  FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Crown Laboratories)

  FDA approved an original application for Nystatin and Triamcinolone Acetonide topical, a generic product from Crown Laboratories.

• FDA approval · 2016-12-20
  FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved Padagis Israel Pharmaceuticals Ltd's Nystatin and Triamcinolone Acetonide as an Original Application (ANDA) for a topical antif…

• FDA approval · 2013-05-21
  FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Cosette Pharmaceuticals, Inc.)

  FDA approved a supplemental application for Ciclopirox Olamine from Cosette Pharmaceuticals, resulting in updated labeling for its topical a…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2010-08-03
  FDA Approved: CLOTRIMAZOLE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved a generic clotrimazole product under an original ANDA from Glenmark Pharmaceuticals Inc., USA.

• FDA approval · 2007-09-18
  FDA Approved: CICLOPIROX — Original Application (Padagis Israel Pharmaceuticals Ltd)

  The FDA approved Ciclopirox as a generic drug under ANDA 077623 from Padagis Israel Pharmaceuticals Ltd.

• FDA approval · 2006-12-15
  FDA Approved: CICLOPIROX OLAMINE — Original Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved Ciclopirox Olamine as a topical antifungal under an original application by Padagis Israel Pharmaceuticals Ltd.

• FDA approval · 2006-10-05
  FDA Approved: MICONAZOLE 7 — Supplemental Application (TARGET Corporation)

  FDA approved a supplemental application for MICONAZOLE 7 (miconazole nitrate) submitted by Target Corporation under ANDA074444. This approva…